These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26771678)

  • 1. Changing Paradigm of Hemophilia Management: Extended Half-Life Factor Concentrates and Gene Therapy.
    Kumar R; Dunn A; Carcao M
    Semin Thromb Hemost; 2016 Feb; 42(1):18-29. PubMed ID: 26771678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003429. PubMed ID: 15846666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The More Recent History of Hemophilia Treatment.
    Franchini M; Mannucci PM
    Semin Thromb Hemost; 2022 Nov; 48(8):904-910. PubMed ID: 36108649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hemophilia.
    Rodeghiero F
    Ric Clin Lab; 1985; 15(4):289-303. PubMed ID: 3914697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promise and challenges of bioengineered recombinant clotting factors.
    Pipe SW
    J Thromb Haemost; 2005 Aug; 3(8):1692-701. PubMed ID: 16102035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current challenges in the management of hemophilia.
    Bauer KA
    Am J Manag Care; 2015 Mar; 21(6 Suppl):S112-22. PubMed ID: 26168206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular approaches for improved clotting factors for hemophilia.
    Kaufman RJ; Powell JS
    Hematology Am Soc Hematol Educ Program; 2013; 2013():30-6. PubMed ID: 24319159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and management of hemophilia].
    Tokugawa T
    Rinsho Ketsueki; 2020; 61(9):1338-1348. PubMed ID: 33162534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2017 Clinical trials update: Innovations in hemophilia therapy.
    Hartmann J; Croteau SE
    Am J Hematol; 2016 Dec; 91(12):1252-1260. PubMed ID: 27563744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life expectancy in hemophilia outcome.
    Mejia-Carvajal C; Czapek EE; Valentino LA
    J Thromb Haemost; 2006 Mar; 4(3):507-9. PubMed ID: 16460431
    [No Abstract]   [Full Text] [Related]  

  • 11. [Status of joint and intracranial bleeding of moderate and severe hemophilia in children under on-demand therapy].
    He WW; Wu RH
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):636-8. PubMed ID: 23158747
    [No Abstract]   [Full Text] [Related]  

  • 12. Longer-acting clotting factor concentrates for hemophilia.
    Powell JS
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S167-75. PubMed ID: 26149018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended Half-Life Coagulation Factors: A New Era in the Management of Hemophilia Patients.
    Ar MC; Balkan C; Kavaklı K
    Turk J Haematol; 2019 Aug; 36(3):141-154. PubMed ID: 31088040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming the challenges of treating hemophilia in resource-limited nations: a focus on medication access and adherence.
    Ghosh K; Ghosh K
    Expert Rev Hematol; 2021 Aug; 14(8):721-730. PubMed ID: 34278926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(1):19-25. PubMed ID: 7796372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophilia therapy: the future has begun.
    Mannucci PM
    Haematologica; 2020 Mar; 105(3):545-553. PubMed ID: 32060150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [NEW INNOVATIONS IN THE TREATMENT OF HEMOPHILIA].
    Levy-Mendelovich S; Brutman-Barazani T; Kenet G
    Harefuah; 2023 Jan; 162(1):47-51. PubMed ID: 36714942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for hemophilia B.
    Mannucci PM; Franchini M
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):407-14. PubMed ID: 25098797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hemophilia in the near future.
    Peyvandi F; Garagiola I
    Semin Thromb Hemost; 2015 Nov; 41(8):838-48. PubMed ID: 25703518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens.
    Oldenburg J
    Blood; 2015 Mar; 125(13):2038-44. PubMed ID: 25712992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.